You are here
Rapid Cystic Fibrosis Mutation Screening Test
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44HL074607-04A2
Agency Tracking Number: HL074607
Amount:
$2,997,640.00
Phase:
Phase II
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2007-2
Timeline
Solicitation Year:
2008
Award Year:
2008
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
PHARMASEQ, INC.
11 DEER PARK DR, STE 104
MONMOUTH JUNCTION, NJ
08852
United States
DUNS:
027661870
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: WLODEK Mandecki
Phone: (973) 972-4483
Email: W.MANDECKI@UMDNJ.EDU
Phone: (973) 972-4483
Email: W.MANDECKI@UMDNJ.EDU
Business Contact
Name: RICHARD MORRIS
Phone: (732) 355-0100
Email: mandecki@pharmaseq.com
Phone: (732) 355-0100
Email: mandecki@pharmaseq.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): We propose to configure a DNA-based assay to detect mutations in the gene related to cystic fibrosis (CF), encoding the cystic fibrosis transmembrane conductance regulator protein (CFTR). The assay will have an extende
* Information listed above is at the time of submission. *